logo

For the Inventor, By the Inventor

Osaka, Japan

Yoshisuke Nakayama

This inventor holds 15 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ono Pharmaceutical Co., Ltd., Ono Pharmaceuticals Co., Ltd.. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshisuke Nakayama. Retrieved from https://idiyas.com/inventor/yoshisuke-nakayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 20.0

 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 100(Granted Patents)


Location History:

  • Osaka, JP (2003 - 2012)
  • Mishima-gun, JP (2005 - 2012)

Company Filing History:

goldMedal14 out of 575 
 
Ono Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 22 
 
Ono Pharmaceuticals Co., Ltd.
 patents

Years Active: 2003-2012

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8318952 - Substituted indole derivatives for the treatment of respiratory diseases (2012-11-27),
2. 8115014 - Ethynylindole compounds (2012-02-14),
3. 7763610 - Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases (2010-07-27),
4. 7728023 - Indole compound and use thereof (2010-06-01),
5. 7560475 - Phenylacetic acid derivative, process for producing the same, and use (2009-07-14),
6. 7323456 - Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient (2008-01-29),
7. 7241784 - Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient (2007-07-10),
8. 7220864 - Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient (2007-05-22),
9. 7211591 - Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient (2007-05-01),
10. 7037914 - Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient (2006-05-02),
11. 6924295 - Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient (2005-08-02),
12. 6821994 - Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient (2004-11-23),
13. 6664281 - Carboxylic acid derivatives and drugs containing the same as the active ingredient (2003-12-16),
14. 6589969 - Carboxylic acid derivatives and drugs containing the same as the active ingredient (2003-07-08),
15. 6506757 - Carboxylic acid derivatives and drugs containing the same as the active ingredient (2003-01-14),

Title: Innovations of Yoshisuke Nakayama

Introduction

Yoshisuke Nakayama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of respiratory diseases. With a total of 15 patents to his name, Nakayama's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents are innovative compounds designed to treat various respiratory conditions. One notable invention is a series of substituted indole derivatives that antagonize cysLT, making them useful for preventing and treating diseases such as bronchial asthma, chronic obstructive pulmonary disease, and severe acute respiratory syndrome. Another significant patent involves ethynylindole compounds, which exhibit potent oral activity and long-lasting effects against cysLT/cysLT receptor antagonism. These compounds are beneficial for treating a range of respiratory ailments, including allergic rhinitis and chronic bronchitis.

Career Highlights

Yoshisuke Nakayama has worked with notable companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His career is marked by a commitment to advancing medical treatments through innovative research and development.

Collaborations

Throughout his career, Nakayama has collaborated with esteemed colleagues such as Hisao Tajima and Daikichi Fukushima. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in respiratory disease treatments.

Conclusion

Yoshisuke Nakayama's contributions to the field of pharmaceuticals, particularly in respiratory disease treatment, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations continue to influence the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…